D. E. Shaw & Co., Inc. Quest Diagnostics Inc Transaction History

D. E. Shaw & Co., Inc.

$98.6 Billion
Q2 2024

A detailed history of D. E. Shaw & Co., Inc. transactions in Quest Diagnostics Inc stock. As of the latest transaction made, D. E. Shaw & Co., Inc. holds 14,169 shares of DGX stock, worth $1.94 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

14,169

Previous 108,671 86.96%

Holding current value

$1.94 Million

Previous $14.5 Million 86.6%

% of portfolio

0.0%

Previous 0.01%

26 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 14, 2024	SELL	$125.91 - $144.34 $11.9 Million - $13.6 Million	-94,502 Reduced 86.96%	14,169 $1.94 Million
Q1 2024 May 15, 2024	BUY	$123.78 - $142.11 $5.92 Million - $6.8 Million	47,849 Added 78.67%	108,671 $14.5 Million
Q4 2023 Feb 14, 2024	BUY	$120.62 - $141.12 $4.63 Million - $5.41 Million	38,347 Added 170.62%	60,822 $8.39 Million
Q3 2023 Nov 14, 2023	SELL	$121.86 - $144.92 $5.89 Million - $7.01 Million	-48,344 Reduced 68.26%	22,475 $2.74 Million
Q2 2023 Aug 14, 2023	SELL	$130.56 - $146.84 $5.04 Million - $5.67 Million	-38,641 Reduced 35.3%	70,819 $9.95 Million
Q1 2023 May 15, 2023	BUY	$131.53 - $155.76 $6.12 Million - $7.25 Million	46,530 Added 73.94%	109,460 $15.5 Million
Q4 2022 Feb 14, 2023	BUY	$123.31 - $157.26 $2.66 Million - $3.39 Million	21,562 Added 52.12%	62,930 $9.84 Million
Q3 2022 Nov 14, 2022	SELL	$121.77 - $141.1 $1.28 Million - $1.48 Million	-10,514 Reduced 20.27%	41,368 $5.08 Million
Q2 2022 Aug 15, 2022	SELL	$127.07 - $145.39 $1.95 Million - $2.23 Million	-15,318 Reduced 22.79%	51,882 $6.9 Million
Q1 2022 May 16, 2022	SELL	$129.09 - $164.35 $40.9 Million - $52.1 Million	-316,975 Reduced 82.51%	67,200 $9.2 Million
Q4 2021 Feb 14, 2022	BUY	$140.36 - $173.01 $27.8 Million - $34.2 Million	197,774 Added 106.1%	384,175 $66.5 Million
Q3 2021 Nov 15, 2021	SELL	$132.95 - $158.0 $11.2 Million - $13.3 Million	-84,377 Reduced 31.16%	186,401 $27.1 Million
Q2 2021 Aug 16, 2021	SELL	$126.66 - $141.48 $1.4 Million - $1.56 Million	-11,041 Reduced 3.92%	270,778 $35.7 Million
Q1 2021 May 17, 2021	BUY	$114.63 - $133.34 $21.2 Million - $24.6 Million	184,722 Added 190.24%	281,819 $36.2 Million
Q4 2020 Feb 16, 2021	BUY	$112.7 - $128.05 $9.38 Million - $10.7 Million	83,235 Added 600.45%	97,097 $11.6 Million
Q1 2020 May 15, 2020	SELL	$75.14 - $115.68 $9.76 Million - $15 Million	-129,936 Reduced 90.36%	13,862 $1.11 Million
Q4 2019 Feb 14, 2020	BUY	$100.29 - $107.99 $13.9 Million - $15 Million	138,604 Added 2668.54%	143,798 $15.4 Million
Q3 2019 Nov 14, 2019	SELL	$97.85 - $107.42 $58,514 - $64,237	-598 Reduced 10.32%	5,194 $556,000
Q2 2019 Aug 14, 2019	SELL	$85.18 - $101.94 $7.22 Million - $8.64 Million	-84,720 Reduced 93.6%	5,792 $590,000
Q1 2019 May 15, 2019	SELL	$80.68 - $89.92 $21.9 Million - $24.5 Million	-272,007 Reduced 75.03%	90,512 $8.14 Million
Q4 2018 Feb 14, 2019	BUY	$79.75 - $108.38 $12.3 Million - $16.7 Million	154,086 Added 73.93%	362,519 $30.2 Million
Q3 2018 Nov 14, 2018	SELL	$105.42 - $114.99 $4.28 Million - $4.67 Million	-40,642 Reduced 16.32%	208,433 $22.5 Million
Q2 2018 Aug 14, 2018	BUY	$97.35 - $113.14 $6.06 Million - $7.04 Million	62,266 Added 33.33%	249,075 $27.4 Million
Q1 2018 May 15, 2018	SELL	$96.42 - $107.88 $21.1 Million - $23.6 Million	-218,560 Reduced 53.92%	186,809 $18.7 Million
Q4 2017 Feb 14, 2018	BUY	$90.86 - $100.24 $35.5 Million - $39.2 Million	391,122 Added 2745.29%	405,369 $39.9 Million
Q3 2017 Nov 14, 2017	BUY	$91.96 - $108.35 $1.31 Million - $1.54 Million	14,247	14,247 $1.33 Million

Others Institutions Holding DGX

# of Institutions

909

Shares Held

96.1M

Call Options Held

587K

Put Options Held

235K

View Full List

About QUEST DIAGNOSTICS INC

Ticker DGX
Exchange NYSE
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 113,887,000
Market Cap $15.6B
Description
Quest Diagnostics Incorporated provides diagnostic testing, information, and services in the United States and internationally. The company develops and delivers diagnostic information services, such as routine testing, non-routine and advanced clinical testing, anatomic pathology testing, and other diagnostic information services. It offers dia...

More about DGX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of D. E. Shaw & Co., Inc., based on Form 13F filings with the SEC.

News

Stay updated on D. E. Shaw & Co., Inc. with notifications on news.

Account